首页> 外国专利> Alpha acid Derivatives hidrocarboxilico heterociclicamente replaced, their use for the preparation of a Pharmaceutical composition, combinations of these derivatives and one or more active substancesPharmaceutical preparations for peroral Administration and Structural fragment from parental and

Alpha acid Derivatives hidrocarboxilico heterociclicamente replaced, their use for the preparation of a Pharmaceutical composition, combinations of these derivatives and one or more active substancesPharmaceutical preparations for peroral Administration and Structural fragment from parental and

机译:取代了α酸衍生物hidrocarboxilico heterociclicamente,将其用于制备药物组合物,这些衍生物和一种或多种活性物质的组合用于经口给药的药物制剂以及来自父母和母亲的结构片段

摘要

Derivatives of the heterocyclicly substituted alpha-hydrocarboxylic acid according to formula (I) wherein R1 means tetrazole or a group of formula II where R has the following meaning: a) an OR5 moiety, wherein R5 means: hydrogen, the cation of an alkali metal , the cation of a physiologically tolerable alkaline earth metal or organic ammonium bond; C3-8 cycloalkyl C1-8 alkyl, CH2-phenyl, C3-8 alkenyl, C3-8 alkylinyl or phenyl optionally substituted. b) a 5-membered heteroaromatic compound, bound through a nitrogen atom, chosen from: pyrrolyl, pyrazolyl, imidazolyl and triazolyl, which can carry one or two halogen atoms,Or 1 to 2 groups of C1-4 tar, or 1 to 2 groups of C1-4 (III) formula.in which k can take the values 0, 1 and 2, p the values 1, 2, 3 and 4 and R6 represents: C1-4 alkyl, C3-8 cycloalkyl, C3-8 alkenyl, C3-8 alkynyl or possibly substituted phenyl ) a residue of formula (IV) wherein R7 means: C1-4 alkyl, C3-8 alkenyl, C3-8 alkynyl, C3-8 cycloalkyl, these being able to carry a C1-4 alkoxy moiety, C1-4 alkylthio and / or a phenyl moiety; C1-4 hologenoalkyl or phenyl, optionally substituted. A means NR8R9, azido, OR10, SR10, or C1-4 alkyl; X means oxygen, sulfur, CR11 or NR12; with the proviso that if X = CR11 then Y = oxygen or sulfur or NR14. Y means oxygen, sulfur, CR13 or NR14;The condition is y = oxygen or sulfur or nr14, eentonces x = cr11. R2 and R3 (may be the same or different) mean: phenyl or naftyl, which will eventually be replaced; ofenero or naftyl; they can be connected in orthogonal form through direct ligation, a methylene, ethylene or etenil group, an oazufe or a SO2, NH or N group (C1-4 tar);Cycloquilo C5-6, which will eventually be replaced; R4 and R11 (which may be the same or different) mean: hydrogen, halogenation, alcox C1-4, halogenated propoxyc1-4, alqueniloxi C3-6, asphalt C3-6, C1-4, C1-4, alcoxilo carbon-4,
机译:根据式(I)的杂环取代的α-氢羧酸的衍生物,其中R 1是四唑或式II的基团,其中R具有以下含义:a)OR 5部分,其中R 5是:氢,碱金属的阳离子,是生理上可耐受的碱土金属或有机铵键的阳离子; C3-8环烷基,C1-8烷基,CH2-苯基,C3-8烯基,C3-8亚烷基或任选取代的苯基。 b)通过氮原子结合的5元杂芳族化合物,其选自:吡咯基,吡唑基,咪唑基和三唑基,其可以带有一个或两个卤素原子,或1-2个C1-4焦油基团,或1-2个C 1-4(III)的基团,其中k可以取值0、1和2,p取值1、2、3和4,R6代表:C1-4烷基,C3-8环烷基,C3-8式(IV)的残基,其中R 7表示:C 1-4烷基,C 3-8烯基,C 3-8炔基,C 3-8环烷基,这些能够携带C 1- 4烷氧基部分,C1-4烷硫基和/或苯基部分;任选被取代的C 1-4异戊烯基烷基或苯基。 A是指NR8R9,叠氮基,OR10,SR10或C1-4烷基; X表示氧,硫,CR 11或NR 12;前提是如果X = CR11,则Y =氧或硫或NR14。 Y表示氧,硫,CR13或NR14;条件为y =氧或硫或nr14,单体x = cr11。 R 2和R 3(可以相同或不同)是指:苯基或萘基,它们最终将被取代;萘甲酚或萘甲酚;它们可以通过直接连接,亚甲基,亚乙基或烯丙基,绿洲或SO2,NH或N基团(C1-4焦油)以正交形式连接;环喹啉C5-6,最终将被取代。 R4和R11(可以相同或不同)是指:氢,卤代,Alcox C1-4,卤代丙氧基C1-4,Alqueniloxi C3-6,沥青C3-6,C1-4,C1-4,Alcoxilo碳4 ,

著录项

  • 公开/公告号AR017581A1

    专利类型

  • 公开/公告日2001-09-12

    原文格式PDF

  • 申请/专利权人 ABBOTT GMBH & CO. KG.;

    申请/专利号AR1998P105651

  • 发明设计人

    申请日1998-11-09

  • 分类号C07D263/38;C07D277/04;C07D233/96;C07D277/60;C07D277/62;A61K31/42;A61K31/425;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号